Streamline Health Solutions, Inc. / Fundamentals
Income statement
- Net revenue
€15.86M - Cost of goods sold
€8.20M - Gross profit
€7.66M - SG&A expenses
€9.78M - R&D expenses
€3.82M - EBITDA
-€1.90M - D&A
€4.12M - EBIT
-€5.94M - Interest expenses
€1.80M - EBT
-€7.82M - Tax expenses
€0.00 - Net income
-€7.82M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€660.22K - Changes in working capital
€300.34K - Operating cash flow
-€1.11M - Capex
€740.49K - Other investing cash flow
-€534.22K - Net investing cash flow
-€740.49K - Total cash dividends paid
€0.00 - Issuance of common stock
€86.07M - Debt repayment
€215.76K - Other financing cash flow
-€484.16K - Net financing cash flow
-€334.86K - Foreign exchange effects
€0.00 - Net change in cash
-€2.18M - Cash at end of period
€1.25M - Free cash flow
-€367.65K
Balance sheet
- Cash and cash equivalents
€1.25M - Cash and short-term investments
€1.25M - Total receivables
€4.16M - Inventory
€0.00 - Other current assets
€267.54K - Total current assets
€5.68M - Property, plant & equipment
€38.84K - Goodwill
€11.46M - Intangible assets
€12.78M - Long-term investments
€0.00 - Other non-current assets
€968.33K - Total non-current assets
€25.24M - Total assets
€30.92M - Accounts payable
€1.34M - Short-term debt
€12.07M - Other current liabilities
€1.73M - Total current liabilities
€21.28M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€100.11K - Total liabilities
€21.38M - Common stock
€37.11K - Retained earnings
-€110.04M - Other equity
€0.00 - Total equity
€9.54M - Total liabilities and shareholders' equity
€30.92M
Company information
- Market capitalization
€19.25M - Employees
70 - Enterprise Value
€33.35M
Company ratios
- Gross margin
-
48.3% Worse than peer group: 58.8% - EBITDA margin
-
-12.0% Worse than peer group: -2.4% - EBIT margin
-
-37.4% Much worse than peer group: -11.6% - EBT margin
-
-49.3% Much better than peer group: -1,022.9% - Net margin
-
-49.3% Much worse than peer group: -14.2% - ROE
-
-82.0% Much worse than peer group: 9.4% - ROA
-
-25.3% Much worse than peer group: 1.7% - Asset turnover
-
51.3% Worse than peer group: 70.7% - FCF margin
-
-11.7% Worse than peer group: -5.3% - FCF yield
-9.6% - Efficiency ratio
112.0% - Net sales per employee
-
€226.61K - Net income per employee
-
-€111.76K